OG
Ori Gutwerg
SVP, Generics

Ori Gutwerg insider trades: Ani Pharmaceuticals (ANIP) stock sales

SVP, Generics, Ani Pharmaceuticals Last trade Aug 10, 2026 25 Form 4 filings
$621K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ori reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 10, 2026ANIP↓ Sell$243K
May 12, 2026ANIP↓ Sell$220K
Mar 3, 2026ANIP↓ Sell$158K
Aug 12, 2025ANIP↓ Sell$508K
May 15, 2025ANIP↓ Sell$53K
Mar 5, 2025ANIP↓ Sell$323K
Jun 5, 2024ANIP↓ Sell$200K
Aug 23, 2023ANIP↓ Sell$971K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANIP insiders

Open-market trades in the last 12 months

About Ori Gutwerg's insider trades

Ori Gutwerg is SVP, Generics at Ani Pharmaceuticals (ANIP). Since Aug 23, 2023, Ori has reported no open-market purchases and 8 sales worth $2.7M on SEC Form 4. In the last 12 months: 3 sales ($621K).

Their filings also include shares withheld for taxes (12 filings), grants and awards (7 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.